Managing Cardiovascular Risk in Elective Total Joint Arthroplasty

Dr Eric Harrison is a specialist in Advanced Cardiac Imaging. He curates a CCTA 5,000 case database and and created the Sherlock Program for predicting cardiac prognosis based on coronary artery plaque morphology, composition, and function to predict cardiac events. He started the company PrivaCors to develop this concept nationally with artificial intelligence. PrivaCors has been chosen by IBM Watson Healthcare to join their 24 company collaborative to implement AI in medical imaging and EKGs. He co-founded Cardio-Oncology a 501 (3) (c) and had our Global International Meeting in Tampa this year and Brazil next year. Founded Cardio-Orthopaedics, a new subspecialty of cardiology to contain the cardiac risk of orthopaedic TJA surgery. This program is in collaboration with Florida Orthopaedic Institution and has resulted in presentation of at ISTA in London this year. Dr Harrison was promoted at USF Morsani College of Medicine to the rank of Collaborative Professor of Medicine and is Adjunct Professor of Joint Special Operations University where he is Co-developing a medical maintenance manual for Special Operations Forces warriors and their physicians. His clinic is very active with patients referred daily for personal coronary plaque management from SOCOM, CENTCOM, the 6th Medical Group, Concierge Practices, Florida Orthopaedic Institute, Florida Cancer Specialists, the City of Tarpon Springs and many other physician practices.

Dr Nick Ho attained his MD degree in 2010 from St. Matthews University of Medicine, Grand Cayman with clinical rotations in Mount Sinai Chicago and Wyckoff Heights in NYC, as well as various community hospitals in those cities. After graduating, he moved into Medical Informatics and research, being hired and working as the lead medical officer at PEPID, LLC since 2011. He decided to get back into clinical medicine in 2020 moving to the Harrison Cardiovascular Center, meeting Dr Harrison, who would train him in CCTA and cardiology, as well as other entrepreneurial endeavors. Dr Harrison involved him in several research studies, including Harrison COVID-19 Research, Cardio-Orthopaedics, and currently the DeBartolo Longevity Foundation, subsidiaries of the Cardiac Society for Bridging Medical Silos, Inc (501c3), which he is currently the Executive Technical Medical Director as well as co-founder.